1、 Market Review
In the past week (as of June 7, 2026), the domestic PA6 market has continued to decline weakly, with the decline gradually expanding, and there is a lack of favorable support for both costs and supply and demand sides. According to the monitoring of Shengyi Society, the benchmark price of PA6 fell from 12300 yuan/ton in early June to 11700 yuan/ton on June 7th, a decrease of about 4.88%.
2、 Cause analysis
The price of core raw material caprolactam continues to weaken, which seriously lacks cost support for PA6. As of early June, the benchmark price of caprolactam has dropped from 12887.50 yuan/ton in early May to 11100 yuan/ton, with a cumulative decline of over 6% in May alone, directly driving down the production cost of PA6. The price decline of caprolactam narrowed in the first week of June, but there has been no signal of a rebound, and the cost side is still bearish.
The supply-demand pattern continues to be weak, with loose supply combined with weak demand, further suppressing prices:
Supply side: The operating rate of PA6 plant remains high, coupled with the concentrated release of new production capacity in the early stage, the overall supply is sufficient; Production enterprises have a strong willingness to ship, generally reducing inventory by exchanging price for quantity. The actual transaction price is generally lower than the listed price, and the industry’s inventory pressure continues to accumulate.
On the demand side, downstream industries such as textiles, synthetic fibers, and modified plastics are facing a shortage of orders, and are currently in the traditional off-season of demand. Enterprises lack confidence in the future market, and their procurement only maintains essential replenishment, resisting high priced raw materials. There has been no centralized procurement behavior, and the market trading atmosphere remains sluggish.
3、 Future forecast
In the short term, negative factors still dominate, and the PA6 market is weak and difficult to change. Prices are likely to continue to decline: downstream terminal demand is unlikely to show significant improvement, and the pace of enterprise destocking is slow. Although the operating load of the PA6 industry may slightly decrease, inventory pressure will continue; The narrowing decline in the price of raw material caprolactam has limited support for PA6, making it difficult to reverse the downward trend. If there is no catalyst for raw material price increases or a significant rebound in terminal orders in the future, it is difficult to have market reversal momentum in the short term.
| http://www.thiourea.net |

